GO:0042816 vitamin B6 metabolic process: Coenzyme Biosynthesis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042816 vitamin B6 metabolic process describes the chemical reactions and pathways involving pyridoxal, pyridoxamine, pyridoxine and the active coenzyme pyridoxal phosphate (PLP).
• Vitamin B6 is an essential micronutrient whose active form PLP is a cofactor for more than 140 enzymatic reactions, including amino acid, carbohydrate and lipid metabolism.
• The pathway is clinically important because deficiency and altered status are linked to inflammation, diabetes, homocystinuria and oxalate-related disorders.
• Key genes include PNPO, PDXK, PNPT1, ALDH7A1, KYNU, AOX1 and TDO2, which control synthesis, salvage, phosphorylation and degradation of B6 vitamers.
• Model organisms such as Drosophila and microbes are used to dissect B6 metabolic flux and to engineer fermentative vitamin B6 production.
• CRISPR knockout, point-mutation, knock-in and overexpression cell models enable causal testing of B6 pathway genes in disease-relevant contexts.
Description
GO:0042816 vitamin B6 metabolic process is the biological process that encompasses all chemical reactions and pathways involving the vitamin B6 family: pyridoxal, pyridoxamine, pyridoxine and the active coenzyme form pyridoxal phosphate (PLP). Vitamin B6 compounds are water-soluble vitamers that must be obtained from the diet or synthesized by microorganisms, and their interconversion is essential for maintaining cellular PLP pools. Because PLP serves as a cofactor in numerous enzymatic reactions, the pathway sits at the intersection of amino acid metabolism, one-carbon metabolism and neurotransmitter synthesis. For researchers, GO:0042816 is a tractable entry point to study micronutrient-dependent metabolism. Clinical chemistry studies have long established methods for measuring B6 vitamers and their metabolites, providing a foundation for modern flux analyses. More recent work has connected vitamin B6 status to inflammatory pathways, diabetes and metabolic reprogramming, making the pathway relevant to immunology, endocrinology and cancer biology. In addition, inherited defects in B6 metabolism cause homocystinuria and pyridoxine-dependent epilepsy, underscoring the medical importance of the pathway. This article integrates the QuickGO definition with verified PubMed literature to summarize the mechanism, key genes, disease links and experimental strategies for studying vitamin B6 metabolic process. It is intended for scientists who need a concise, citable overview before designing CRISPR screens, metabolomic experiments or therapeutic hypotheses.
vitamin B6 metabolic process At A Glance
| GO ID | GO:0042816 |
|---|---|
| GO term | vitamin B6 metabolic process |
| Ontology | biological_process |
| Synonym | vitamin B6 metabolism |
| Definition | The chemical reactions and pathways involving any of the vitamin B6 compounds: pyridoxal, pyridoxamine and pyridoxine and the active form, pyridoxal phosphate. |
| Major function | Maintains cellular pools of pyridoxal phosphate (PLP), a coenzyme required for amino acid, carbohydrate and lipid metabolism. |
| Key vitamers | Pyridoxal, pyridoxamine, pyridoxine and pyridoxal phosphate (PLP). |
| Representative genes | PNPO, PDXK, PNPT1, ALDH7A1, KYNU, AOX1, TDO2. |
| Clinical relevance | Vitamin B6 status is associated with inflammation, diabetes, homocystinuria and oxalate metabolism disorders. |
What Is GO:0042816?
In our own words, GO:0042816 vitamin B6 metabolic process refers to the collection of biochemical reactions and pathways that produce, interconvert, activate, salvage and degrade the vitamin B6 compounds pyridoxal, pyridoxamine and pyridoxine, as well as their phosphorylated active form pyridoxal phosphate (PLP). The term covers both the de novo synthesis of B6 vitamers in microorganisms and the salvage and phosphorylation steps that maintain PLP availability in mammalian cells. It also includes reactions that consume PLP as a cofactor and pathways that catabolize B6 vitamers to excretory products.
Why Is vitamin B6 metabolic process Important in Cell Biology?
Vitamin B6 metabolic process is important because it controls the availability of pyridoxal phosphate, a coenzyme that participates in more than 140 enzymatic reactions, including transamination, decarboxylation, racemization and elimination reactions. Perturbations in this pathway alter amino acid and one-carbon metabolism, influence inflammatory signaling and can contribute to metabolic disease. Clinically, vitamin B6 deficiency and inborn errors of B6 metabolism present with neurological, hematological and metabolic phenotypes, and B6 status is a modifiable factor in homocystinuria management. Therefore, understanding GO:0042816 is essential for nutrition science, neurobiology, metabolic engineering and drug development.
• PLP, the active form of vitamin B6, is a cofactor for over 140 enzymes, making the pathway central to amino acid and neurotransmitter metabolism.
• Vitamin B6 status is inversely associated with markers of inflammation, and the pathway interacts with one-carbon and kynurenine metabolism.
• Altered vitamin B6 metabolism has been linked to diabetes and its molecular complications, including advanced glycation and oxidative stress.
• Inherited defects in B6 metabolism, such as pyridoxine-dependent epilepsy and homocystinuria, are directly caused by pathway dysfunction.
• Vitamin B6 is involved in oxalate metabolism, and deficiency can alter urinary oxalate excretion, linking the pathway to kidney stone biology.
• Microbial vitamin B6 metabolism is exploited for fermentative production of the vitamin, with biotechnological and industrial relevance.
• Drosophila models of vitamin B6 deficiency reveal conserved metabolic alterations, supporting the use of invertebrate systems for pathway discovery.
• Clinical chemistry methods for B6 vitamers provide quantitative readouts for diagnosing deficiency and monitoring supplementation.
• The pathway is a target for CRISPR functional genomics because many B6-related genes remain incompletely characterized in human cells.
• Understanding B6 metabolism supports precision nutrition and therapeutic strategies for metabolic and neurological disorders.
What Happens During vitamin B6 metabolic process?
Uptake and phosphorylation of B6 vitamers
In simple terms: Cells take up vitamin B6 from the environment and add a phosphate group to trap it inside.
In mammalian cells, dietary pyridoxine, pyridoxamine and pyridoxal are transported into cells and phosphorylated by pyridoxal kinase (PDXK) to form pyridoxine phosphate, pyridoxamine phosphate and pyridoxal phosphate (PLP). Phosphorylation serves as a retention mechanism because phosphorylated vitamers cannot easily cross membranes. PLP is the central active form and is used by enzymes throughout the cell. The clinical chemistry of vitamin B6 has historically relied on measuring these phosphorylated and non-phosphorylated species to assess status.
Interconversion of B6 vitamers
In simple terms: The different forms of vitamin B6 can be converted into each other so the cell always has the active form available.
Pyridoxine phosphate and pyridoxamine phosphate are oxidized or aminated to generate PLP, and PLP can be dephosphorylated to pyridoxal for export or further metabolism. These interconversions are catalyzed by oxidases and aminotransferases that maintain the balance among vitamers. The pathway ensures that PLP supply matches demand from PLP-dependent enzymes. Inborn errors affecting these steps can cause accumulation of upstream vitamers and neurological symptoms.
PLP-dependent catalysis and cofactor recycling
In simple terms: PLP acts as a reusable tool that helps enzymes perform chemical reactions, especially with amino acids.
PLP functions as a coenzyme in transamination, decarboxylation, deamination and other reactions by forming a Schiff base with substrate amino groups. After catalysis, PLP is regenerated through the action of pyridoxal kinase and other salvage enzymes, allowing continued catalytic cycles. Because PLP is reactive, its intracellular concentration is tightly controlled to avoid toxicity. This recycling is a core feature of GO:0042816.
Salvage and degradation of B6 vitamers
In simple terms: The cell can recycle used vitamin B6 or break it down and excrete it when there is too much.
Salvage pathways recover pyridoxal and pyridoxamine from PLP-dependent enzyme turnover, while excess B6 is catabolized to excretory products such as 4-pyridoxic acid. Degradation involves aldehyde oxidase and other oxidases that convert pyridoxal to 4-pyridoxic acid, which is excreted in urine. Inborn errors in degradation or salvage can disturb B6 homeostasis and contribute to disease. The balance between salvage and degradation determines whole-body B6 status.
De novo synthesis in microorganisms
In simple terms: Bacteria and fungi can build vitamin B6 from scratch, unlike humans who must obtain it from the diet.
Microorganisms synthesize vitamin B6 de novo through the PdxA/PdxJ or Pdx1/Pdx2 pathways, which condense sugar and amino acid precursors into pyridoxine phosphate or pyridoxal phosphate. These pathways are absent in humans, making them attractive targets for antimicrobials and for metabolic engineering of vitamin production. Fermentative production of vitamin B6 relies on optimizing these microbial pathways. Studying microbial B6 synthesis provides evolutionary context for the mammalian salvage pathway.
Key Genes Involved in GO:0042816 vitamin B6 metabolic process
The following genes and proteins are central to vitamin B6 metabolic process, based on their established roles in B6 synthesis, salvage, phosphorylation, degradation and PLP-dependent metabolism.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PDXK | Phosphorylates pyridoxine, pyridoxamine and pyridoxal to their phosphate forms, including PLP | Key target for modulating intracellular PLP levels; knockout models show altered B6 homeostasis |
| PNPO | Pyridoxamine 5'-phosphate oxidase converts pyridoxine phosphate and pyridoxamine phosphate to PLP | Mutations cause pyridoxine-dependent epilepsy; important for neurological disease models |
| PNPT1 | Mitochondrial polynucleotide phosphorylase involved in RNA processing and B6-related metabolism | Links B6 metabolism to mitochondrial RNA metabolism; candidate for functional genomics |
| ALDH7A1 | Aldehyde dehydrogenase family member implicated in pyridoxine-dependent epilepsy and lysine degradation | Disease gene for pyridoxine-dependent epilepsy; knockout models used to study seizure mechanisms |
| KYNU | Kynureninase, a PLP-dependent enzyme in the kynurenine pathway | Connects B6 status to inflammation and immune regulation; relevant to inflammatory disease models |
| TDO2 | Tryptophan 2,3-dioxygenase, a heme enzyme in tryptophan catabolism influenced by B6 status | Used to study cross-talk between B6 and kynurenine pathways |
| AOX1 | Aldehyde oxidase contributes to pyridoxal catabolism to 4-pyridoxic acid | Relevant to B6 degradation and excretion studies |
| PDX1 | Microbial de novo vitamin B6 synthesis enzyme (Pdx1/Pdx2 pathway) | Target for fermentative vitamin B6 production and antimicrobial development |
| PDX2 | Microbial glutaminase involved in de novo vitamin B6 synthesis | Biotechnological target for vitamin B6 overproduction |
| PdxA | Microbial enzyme in the PdxA/PdxJ de novo B6 synthesis pathway | Model for pathway engineering in bacteria |
| PdxJ | Microbial enzyme in the PdxA/PdxJ de novo B6 synthesis pathway | Used in synthetic biology for vitamin production |
| GAD1 | Glutamate decarboxylase, a PLP-dependent enzyme producing GABA | Links B6 metabolism to neurotransmitter synthesis; relevant to neurology |
| GAD2 | Glutamate decarboxylase isoform, PLP-dependent GABA synthesis | Target for studying B6-dependent inhibitory neurotransmission |
| SHMT1 | Serine hydroxymethyltransferase, a PLP-dependent enzyme in one-carbon metabolism | Connects B6 to folate and methylation pathways |
| SHMT2 | Mitochondrial serine hydroxymethyltransferase, PLP-dependent | Relevant to cancer metabolism and mitochondrial B6 biology |
| CBS | Cystathionine beta-synthase, PLP-dependent enzyme in homocysteine metabolism | Disease gene for homocystinuria; B6-responsive in some patients |
| OTC | Ornithine transcarbamylase, indirectly linked to B6-dependent amino acid metabolism | Model for studying B6 in urea cycle-related metabolism |
| MTHFR | Methylenetetrahydrofolate reductase, interacts with B6-dependent one-carbon metabolism | Candidate for gene-nutrient interaction studies |
How Is vitamin B6 metabolic process Regulated?
Vitamin B6 metabolic process is regulated at multiple levels. Intracellular PLP levels are controlled by the balance between phosphorylation by PDXK, oxidation by PNPO and degradation by aldehyde oxidases. Because PLP is reactive, its free concentration is buffered by binding to proteins and by feedback inhibition of B6-metabolizing enzymes. Inflammatory signals can alter B6 status, and the kynurenine pathway, which is PLP-dependent, is induced by inflammatory cytokines, creating a feedback loop between inflammation and B6 metabolism. Hormonal and nutritional factors also influence B6 status, and diabetes-associated metabolic changes can affect PLP availability. In microorganisms, B6 synthesis is regulated by nutrient availability and by the expression of pdx genes, which are subject to transcriptional control.
vitamin B6 metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ALDH7A1 | Pyridoxine-dependent epilepsy | Knockout or point-mutation cell and animal models to study seizure susceptibility |
| PNPO | Pyridoxine-dependent epilepsy and PLP-responsive seizures | Knock-in of patient mutations in neuronal cell lines |
| CBS | Homocystinuria, B6-responsive | CRISPR point-mutation models to test B6 responsiveness |
| PDXK | Altered B6 homeostasis and neuropathy risk | Knockout cell models with metabolomic profiling |
| KYNU | Inflammation and immune dysregulation | Overexpression and knockout models in immune cells |
Vitamin B6 deficiency and neurological disorders
Vitamin B6 deficiency can cause peripheral neuropathy, seizures and anemia, and severe deficiency during development leads to neurological impairment. Inborn errors of B6 metabolism, such as pyridoxine-dependent epilepsy caused by mutations in ALDH7A1 or PNPO, present with seizures that respond to pyridoxine or PLP supplementation. These disorders directly implicate GO:0042816 in neuronal excitability and neurotransmitter synthesis. Clinical chemistry methods for B6 vitamers are essential for diagnosis and monitoring.
Inflammation and immune regulation
Vitamin B6 status is inversely associated with systemic inflammation, and PLP is required for kynurenine pathway enzymes that modulate immune responses. Chronic inflammation can deplete B6 pools, and low B6 status may in turn exacerbate inflammatory signaling. This bidirectional relationship makes GO:0042816 relevant to autoimmune, infectious and chronic inflammatory diseases. Experimental models using cytokine stimulation and B6 restriction help dissect these interactions.
Diabetes and metabolic syndrome
Altered vitamin B6 metabolism has been linked to diabetes and its complications, with evidence for effects on glucose homeostasis, advanced glycation and oxidative stress. Low PLP levels are commonly observed in diabetic patients, and B6 status may influence disease progression. Molecular mechanisms include PLP-dependent enzymes in amino acid and one-carbon metabolism. Studying GO:0042816 in diabetic models can reveal new therapeutic targets.
Homocystinuria and oxalate metabolism
Homocystinuria is an inborn error of methionine metabolism in which cystathionine beta-synthase, a PLP-dependent enzyme, is defective; some patients respond to high-dose vitamin B6. Vitamin B6 also influences oxalate metabolism, and deficiency can alter urinary oxalate excretion, linking the pathway to kidney stone formation. These examples show how GO:0042816 intersects with amino acid and mineral metabolism. Therapeutic approaches often include B6 supplementation as a first-line intervention.
From vitamin B6 metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PDXK alter intracellular PLP levels? | CRISPR knockout of PDXK in human cell lines followed by metabolomics |
| Do patient mutations in PNPO cause enzyme instability? | Point-mutation knock-in of PNPO variants in neuronal cells |
| Can B6-responsive CBS variants be identified? | Knock-in of CBS mutations and dose-response to pyridoxine |
| What is the effect of B6 pathway gene overexpression on proliferation? | Overexpression of PDXK or PNPO in cancer cell lines |
| How does B6 deficiency remodel metabolism? | Drosophila B6 deficiency models with metabolomic analysis |
| Can microbial B6 synthesis be enhanced? | Overexpression of pdx genes in bacteria for fermentative production |
How to Study the vitamin B6 metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS metabolomics | Levels of B6 vitamers and PLP | Quantifying pathway flux in knockout cells |
| CRISPR knockout screening | Gene essentiality and B6 dependence | Identifying modifiers of B6 metabolism |
| Enzyme activity assay | PDXK or PNPO catalytic activity | Validating point mutations |
| RNA-seq | Transcriptional changes in B6 pathway genes | Studying inflammation-driven regulation |
| Proteomics | Protein abundance and interactions | Mapping B6 enzyme complexes |
| Drosophila genetics | Organismal effects of B6 deficiency | Conserved pathway discovery |
| Clinical chemistry assays | B6 status biomarkers | Diagnosis and monitoring of deficiency |
| Microbial fermentation | Vitamin B6 production yield | Biotechnological strain engineering |
Metabolomics and vitamin B6 quantification
Mass spectrometry-based metabolomics allows quantification of pyridoxal, pyridoxamine, pyridoxine and PLP in cells and tissues. Clinical chemistry methods have long provided reference techniques for measuring B6 vitamers and 4-pyridoxic acid. These approaches are essential for validating CRISPR models of B6 pathway genes. Drosophila B6 deficiency models have been characterized using metabolomic profiling.
CRISPR functional genomics and screening
Pooled CRISPR knockout screens can identify genes that modify B6 dependence or PLP sensitivity. Candidate genes such as PDXK, PNPO and KYNU can be tested individually using knockout or point-mutation models. Library screening with bioinformatics analysis helps prioritize B6-related genes for follow-up. This approach is scalable and compatible with disease-relevant cell types.
Enzyme activity and protein interaction assays
Recombinant enzymes such as PDXK and PNPO can be assayed for catalytic activity using spectrophotometric or fluorometric methods. Protein interaction studies can reveal how B6 enzymes are regulated by binding partners. These assays complement cellular models and provide mechanistic insight. They are also used in microbial B6 production optimization.
Animal and invertebrate models
Drosophila models of vitamin B6 deficiency reveal conserved metabolic alterations and can be used for genetic screens. Rodent models are used to study B6 deficiency during development and in adult metabolism. These models help connect cellular findings to organismal physiology. They are also used to test B6 supplementation strategies.
How CRISPR Can Be Used to Study GO:0042816 vitamin B6 metabolic process
Knockout
CRISPR knockout of genes such as PDXK, PNPO or KYNU can reveal their requirement for maintaining PLP levels and cellular fitness. Knockout cell lines are useful for metabolomic profiling and for testing sensitivity to B6 restriction. These models help distinguish between redundant and essential B6 pathway components. They are also used in pooled screens to identify synthetic lethal interactions.
Point Mutation
Point-mutation knock-in of patient variants in PNPO, ALDH7A1 or CBS allows functional assessment of disease-associated alleles. These models can test whether a variant impairs enzyme activity or stability. They are valuable for genotype-phenotype correlation and for drug response studies. CRISPR base editing can introduce precise mutations without double-strand breaks.
Knock-in
Knock-in of tagged versions of B6 enzymes, such as GFP-PDXK, enables localization and interaction studies. Knock-in of reporter cassettes can monitor pathway activity in live cells. These models are useful for imaging and proteomic analyses. They also facilitate the study of B6 enzyme trafficking.
Overexpression
Overexpression of B6 pathway genes can test whether increased PLP synthesis promotes proliferation or stress resistance. Overexpression models are used in cancer metabolism and diabetes research. They can also be applied to microbial strains for fermentative vitamin B6 production. Combining overexpression with metabolomics reveals flux bottlenecks.
How EDITGENE Supports vitamin B6 metabolic process Research
Researchers studying vitamin B6 metabolic process-related genes often need to determine whether a candidate gene is causally involved in maintaining PLP homeostasis, responding to B6 availability or contributing to disease phenotypes. EDITGENE provides the CRISPR tools and cell models required to move from correlation to causation in this pathway.
Contact EDITGENE today to design your custom CRISPR model for vitamin B6 metabolic process research.
Frequently Asked Questions About vitamin B6 metabolic process
What is GO:0042816 vitamin B6 metabolic process?
GO:0042816 is a Gene Ontology biological process term describing the chemical reactions and pathways involving pyridoxal, pyridoxamine, pyridoxine and the active form pyridoxal phosphate (PLP).
What genes are involved in vitamin B6 metabolic process?
Key genes include PDXK, PNPO, PNPT1, ALDH7A1, KYNU, AOX1, TDO2, and microbial pdx genes, all of which contribute to B6 synthesis, salvage, phosphorylation or degradation.
Why is vitamin B6 metabolism important for health?
PLP is a cofactor for over 140 enzymes, and B6 status influences amino acid metabolism, neurotransmitter synthesis, inflammation and diabetes risk.
What diseases are linked to vitamin B6 metabolic process?
Disorders include pyridoxine-dependent epilepsy, homocystinuria, peripheral neuropathy, anemia and altered oxalate metabolism.
How is vitamin B6 metabolic process studied?
Researchers use LC-MS metabolomics, enzyme activity assays, CRISPR knockout screens, RNA-seq and model organisms such as Drosophila.
What is the role of PDXK in vitamin B6 metabolism?
PDXK phosphorylates pyridoxine, pyridoxamine and pyridoxal to their phosphate forms, including PLP, and is essential for maintaining intracellular B6 pools.
What is the role of PNPO in vitamin B6 metabolism?
PNPO catalyzes the oxidation of pyridoxine phosphate and pyridoxamine phosphate to PLP, and mutations in PNPO cause pyridoxine-dependent epilepsy.
Can CRISPR be used to study vitamin B6 metabolism?
Yes, CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of B6 pathway genes in human cells.
How does inflammation affect vitamin B6 status?
Inflammatory cytokines can alter B6 metabolism and kynurenine pathway flux, and low B6 status is associated with increased inflammation.
Is vitamin B6 metabolism involved in diabetes?
Yes, altered B6 metabolism has been linked to diabetes and its complications, with PLP affecting glucose homeostasis and oxidative stress.
Conclusion
GO:0042816 vitamin B6 metabolic process is a central metabolic pathway that maintains pyridoxal phosphate, a coenzyme required for amino acid, neurotransmitter and one-carbon metabolism. Its dysfunction is linked to neurological, inflammatory and metabolic diseases, making it a compelling target for functional genomics. Advances in CRISPR modeling and metabolomics now allow researchers to dissect the pathway with unprecedented precision. By combining QuickGO annotation with verified literature, this overview provides a foundation for designing experiments on B6 metabolism. EDITGENE offers the cell models and screening services needed to translate these insights into causal discoveries.
References
- 1. Stach K et al.. 2021. Vitamin B6 in Health and Disease.. Nutrients 13(9) PMID: 34579110
- 2. Tesoriere G et al.. 2025. Vitamin B6 deficiency produces metabolic alterations in Drosophila.. Metabolomics 21(2):42 PMID: 40123014
- 3. Wilson RG et al.. 1983. Clinical chemistry of vitamin B6.. Adv Clin Chem 23:1-68 PMID: 6398613
- 4. Ueland PM et al.. 2017. Inflammation, vitamin B6 and related pathways.. Mol Aspects Med 53:10-27 PMID: 27593095
- 5. Mascolo E et al.. 2020. Vitamin B6 and Diabetes: Relationship and Molecular Mechanisms.. Int J Mol Sci 21(10) PMID: 32456137
- 6. Kumar T et al.. 2016. Homocystinuria: Therapeutic approach.. Clin Chim Acta 458:55-62 PMID: 27059523
- 7. Rosenberg J et al.. 2017. Vitamin B6 metabolism in microbes and approaches for fermentative production.. Biotechnol Adv 35(1):31-40 PMID: 27890703
- 8. GERSHOFF SN. 1964. VITAMIN B6 AND OXALATE METABOLISM.. Vitam Horm 22:581-9 PMID: 14284120
